| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-06 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.18 | 9e-06 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |